EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment and outcome of vancomycin-resistant enterococcal infection in liver transplant recipients with linezolid



Treatment and outcome of vancomycin-resistant enterococcal infection in liver transplant recipients with linezolid



Clinical Infectious Diseases 31(1): 278, July




(PDF 0-2 workdays service: $29.90)

Accession: 035980000

Download citation: RISBibTeXText



Related references

Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clinical Infectious Diseases 42(2): 195-203, 2005

Linezolid-resistant vancomycin-resistant enterococcal infections in liver transplant patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 314, 2002

Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transplantation 7(1): 27-31, 2001

Successful treatment of vancomycin-resistant enterococcal peritonitis with linezolid in a kidney transplant patient: a case report and review of the literature. Peritoneal Dialysis International 24(1): 70-72, 2004

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clinical Therapeutics 32(10): 1713-1719, 2011

Vancomycin-resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid. Transplant Infectious Disease 15(1): E1-E4, 2013

Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial. Transplant Infectious Disease 5(3): 121-125, 2003

Linezolid for treatment of vancomycin-resistant enterococcal peritonitis. American Journal of Kidney Diseases 38(4): E20-E20, 2001

Emergence of linezolid-resistant Enterococcus faecium in the gastrointestinal tract during treatment of vancomycin-resistant enterococcal infections. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 409, 2001

The use of linezolid in the treatment of vancomycin-resistant enterococcal septicaemia in two patients with burn injuries. Burns 28(2): 185-188, 2002

Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review. International Journal of Clinical Pharmacy 35(5): 697-703, 2014

Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Military Medicine 173(9): 927-929, 2008

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leukemia & Lymphoma 55(12): 2858-2865, 2015

Enterococcal infection in kidney transplant recipients in a setting of low prevalence of vancomycin resistance. Transplant Infectious Disease 16(4): 692-695, 2015

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. Bmc Infectious Diseases 14(): 687-687, 2015